Skip to main content
Premium Trial:

Request an Annual Quote

IGeneX Lyme Disease and Tick-Borne Relapsing Fever Tests

IGeneX, a CLIA and New York-approved reference lab, launched three new tests for diagnosing Lyme disease and Tick-Borne Relapsing Fever, also known as TBRF. The Lyme ImmunoBlot IgM and IgG tests are inclusive for detection of most species of B. burgdorferi, which is one of the two groups of Borrelia that causes disease. The TBRF ImmunoBlots IgM and IgG tests are designed to detect antibodies to specific antigens of TBRF Borrelia in human serum, specifically antibodies to B. hermsii, B. miyamotoi, B. turicatae, and B. coriaceae. The Lyme IGXSpot test is an enzyme-linked immunoSpot, also known as an ELISPOT assay, which detects human T cells reactive to B. burgdorferi specific antigens.